Breaks Categories: Stock Spotlights

FridayFeb 17, 2017 10:42 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) Takes Aim at Growing Digital Ad Markets

As a progressive Internet advertising firm, Social Reality (NASDAQ: SRAX) has its sights on the worldwide real-time bidding (RTB) and social media advertising markets. “Designed to position itself in these multi-billion dollar markets, Social Reality, Inc. is a multi-platform company specializing in digital advertising. Its Social Reality Ad Exchange is a real-time buying and selling management platform designed for launching social media and other campaigns. SRAX Social offers targeted ad purchasing in the digital marketplace, while SRAX.md is designed to help clients reach health care professionals.” To view the full article, visit: http://nnw.fm/CkN0u About Social Reality Social Reality, Inc. is…

Continue Reading

FridayFeb 17, 2017 9:57 am

NetworkNewsBreaks – Heat Biologics, Inc. (NASDAQ: HTBX) Shares Climb following Presentation of Positive Immune Data on HS-410 Phase 2 Bladder Cancer Trial

Shares of Heat Biologics (NASDAQ: HTBX) are up 8% on news that the company presented immunological data from its phase 2 trial evaluating HS-410 either alone or in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) at the 2017 Genitourinary Cancers Symposium. Researchers reported that HS-410, in combination with BCG, is generally well-tolerated, and that HS-410 activates CD8+ T cells and that these immune responders appear to have a lower recurrence rate than non-immune responders. Overall, this data strengthens support for the vaccine mechanism of action and clinical proof-of-concept of immune activation. “These data continue to support…

Continue Reading

ThursdayFeb 16, 2017 11:51 am

NetworkNewsBreaks – Superconductor Technologies, Inc. (NASDAQ: SCON) Shares Surge on New Patent for Manufacturing Process

Superconductor Technologies (NASDAQ: SCON) (“STI”) shares are 35% higher this morning on news that the company was granted a U.S. Patent for STI’s proprietary superconducting wire manufacturing method. This patented process improves Conductus® wire’s performance in the presence of a strong magnetic field, a key enabler for the superconducting applications of the future. Using a technique called pinning, superconducting wire performance is significantly improved. The traditional method involves adding more elements when manufacturing the superconducting layer, thereby increasing the complexity of an already challenging process. This patent provides additional protection for STI’s unique manufacturing process. “STI has demonstrated the ability…

Continue Reading

WednesdayFeb 15, 2017 12:38 pm

NetworkNewsBreaks – TapImmune, Inc. (NASDAQ: TPIV) Receives Positive DSMB Safety Review for TPIV 200, Advances Phase 2 Trial

TapImmune (NASDAQ: TPIV) this morning said it has received a positive recommendation from an independent Data Safety Monitoring Board (DSMB) regarding the company’s lead cancer vaccine candidate, TPIV 200, to continue dosing triple-negative breast cancer (TNBC) patients in an ongoing phase 2 clinical trial. The planned safety review was conducted when enrollment was at 25 percent (20/80 patients). The four-arm trial is designed to test the safety, dosing level and optimal treatment regimen of TPIV 200 against TNBC cells. TapImmune will enroll the remaining patients at 12 clinical centers in the U.S., with enrollment completion targeted for the end of…

Continue Reading

WednesdayFeb 15, 2017 11:08 am

NetworkNewsBreaks – Sino-Global (NASDAQ: SINO) Shares Drop on News of $4.77M Registered Direct Offering

Sino-Global (NASDAQ: SINO) shares fell 21% after the company this morning announced that it has entered into definitive agreements with three institutional investors to purchase a total of $4.77 million of its common stock in a registered direct offering at $3.18 per share. The company, a non-asset based global shipping and freight logistic integrated solution provider, estimates that the net proceeds from the offering will be approximately $4.3 million after deducting estimated offering expenses and placement agent fees. Sino-Global will use the net proceeds of the offering for working capital and general corporate purposes. The offering is expected to close on or about February 21, 2017. To view the…

Continue Reading

WednesdayFeb 15, 2017 11:04 am

NetworkNewsBreaks – Qualstar Corp.’s (NASDAQ: QBAK) N2Power Division Receives $1.0M Order; Shares Rise

Shares of Qualstar (NASDAQ: QBAK) rose 14% this morning on news that the company’s N2Power Division has received a $1.0 million order from a significant gaming customer that's expected to ship over the next 12 months. The N2Power Division is engaged in the design and manufacture of compact and highly-efficient power supplies and provides standard, semi-custom and custom power solutions for many original equipment manufacturers (OEM) in various markets. “The inherent advantages of our power solutions provide OEM designers with valuable increased functionality while reducing thermal loads, cooling requirements and lowering operating costs through very high efficiency ratings,” N2Power’s director…

Continue Reading

TuesdayFeb 14, 2017 10:09 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Featured in Exclusive Audio Interview with NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire this morning announced the availability of a new audio interview with SinglePoint, Inc. (OTC: SING) CEO Greg Lambrecht. In the interview, which can be heard at http://NNW.fm/SING-interview-Feb-2017, Lambrecht gives prospective investors some insight into the company’s SingleSeed Payments subsidiary, which aims to offer electronic banking services to businesses operating in the burgeoning cannabis industry. With a total of 28 states currently allowing medicinal cannabis use, industry advocates expect banks to begin offering financial services to related businesses sooner rather than later, creating a potentially sizable opportunity for SinglePoint to capitalize on its early-mover…

Continue Reading

MondayFeb 13, 2017 10:33 am

NetworkNewsBreaks – Inventergy Global, Inc. (NASDAQ: INVT) Inks LOI with Approach Me, Inc.; Shares Higher

Inventergy Global (NASDAQ: INVT) shares are higher this morning on news that the company’s technology licensing subsidiary, Inventergy Innovations LLC, has entered into a letter of intent with Approach Me, Inc., a company that develops location-based mobile applications. Per the agreement, Inventergy will obtain commercialization rights to Approach Me's technology. Research and Markets, a market research firm, estimates the annual global market for location-based services to reach $34.8 billion by 2020, growing at over 22 percent annually. "Location-based mobile applications and services are high growth markets and we are excited to partner with Approach Me to monetize its unique innovations.…

Continue Reading

FridayFeb 10, 2017 3:55 pm

NetworkNewsBreaks – Newtek Business Services Corp. (NASDAQ: NEWT) at a Glance

Newtek Business Services (NASDAQ: NEWT), Your Business Solutions Company®, is an internally managed Business Development Company which, along with its controlled portfolio companies, provides a wide range of business services and financial products under the Newtek® brand to the small- and medium-sized business ("SMB") market. Since 1999, Newtek has provided state-of-the-art, cost-efficient products and services and efficient business strategies to over 100,000 SMB accounts across all 50 states to help them grow their sales, control their expenses and reduce their risk. Newtek and its portfolio companies' products and services include: business lending, SBA lending solutions, electronic payment processing, technology solutions…

Continue Reading

FridayFeb 10, 2017 12:36 pm

NetworkNewsBreaks – Jaguar Animal Health, Inc. (NASDAQ: JAGX) Merger with Napo Pharmaceuticals Creates Significant Revenue Opportunities

In a move that captures synergistic and revenue-generating benefits, Jaguar Animal Health (NASDAQ: JAGX) is merging with San Francisco-based Napo Pharmaceuticals, Inc. The merger of the two companies is expected to provide Jaguar with a significant prescription revenue stream from sales of Mytesi™, which is FDA-approved for the symptomatic relief of noninfectious diarrhea in human adults with HIV/AIDS on antiretroviral therapy. The estimated U.S. market potential for Mytesti™, which launched in October 2016, is approximately $100 million in gross annual sales; the companies forecast the product will generate approximately $7.0 million in net sales in 2017. The active pharmaceutical ingredient…

Continue Reading